aTyr Pharma share price logo

aTyr Pharma

NASDAQ: ATYR

$0.34

-0.04

(-10.02%)

as on

aTyr Pharma Stock Performance

as on September 25, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $0.32
    $0.41
    downward going graph

    5.21%

    Downside

    21.45%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.32
    $1.12
    downward going graph

    4.03%

    Downside

    231.75%

    Upside

    downward going graph

aTyr Pharma share price movements today

Previous Close
$0.38
Open
$0.40
Volume
24.0M
Market Cap
$36.8M
Day's Low - High
$0.32 - $0.41
52 Week Low - High
$0.32 - $1.12

aTyr Pharma Historical Returns

1 Month Return
-40.77 %
3 Month Return
-39.68 %
1 Year Return
-62.21 %
3 Year Return
0 %
5 Year Return
0 %

aTyr Pharma Stock Fundamentals & Key Indicators

Check aTyr Pharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$36.8M

EPS (TTM)

-0.62

Dividend Yield

0.00%

PE Ratio (TTM)

-0.61

Industry PE ratio

-2.69

PEG Ratio

-0.02429588725387109

Return On Equity TTM

-95.59%

aTyr Pharma Stock Valuation

Track how aTyr Pharma P/E has moved over time to understand its valuation trends.

aTyr Pharma in the last 5 years

  • Overview

  • Trends

Lowest (-4.21x)

December 31, 2024

Industry (-2.69x)

December 31, 2025

Today (-0.98x)

December 31, 2025

Highest (-0.98x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: -0.98x

aTyr Pharma vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of aTyr Pharma with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
aTyr Pharma image
aTyr Pharma
Neutral$36.8MNA-0.61-11754.74%0.00%
Moderna image
Moderna
Neutral$72.7B-54.71%-22.82-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$130.9B184.51%29.8186.04%0.00%
Regeneron image
Regeneron
Buy$82.8B24.59%19.1584.86%0.46%

Stock Returns calculator for aTyr Pharma Stock including INR - Dollar returns

The aTyr Pharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

aTyr Pharma investment value today

Current value as on today

₹40,787

Returns

-₹59,213

(-59.21%)

Returns from aTyr Pharma Stock

-₹62,208 (-62.21%)

Dollar Impact

₹2,995 (+3%)

Analyst Recommendation on aTyr Pharma Stock

Based on 5 analysts

HOLD

20.00%

Buy

80.00%

Hold

0.00%

Sell

Based on 5 analysts, 80% of analysts recommend a 'HOLD' rating for aTyr Pharma. Average target price of $3

Indian Investors' Interest in aTyr Pharma Stock

Search interest for aTyr Pharma Stock has increased by 26% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:26% versus previous 30 day period

aTyr Pharma Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
0
-
-
-
-
-
0
-
-
-
Gross Profit
0
-
-
-12
-
-
-21
-
0
-
Operating Income
-16
-17
-18
-15
-15
-20
-26
-14
-11
-10
EBITDA
-14
-15
-16
-14
-14
-19
-25
-13
-10
-8
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
1
Income Before Tax
-15
-16
-17
-14
-14
-19
-25
-13
-10
-10
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-15
-16
-17
-14
-14
-19
-25
-13
-10
-10
Net Profit Margin
100.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-11547.37%
0.00%
0.00%
0.00%

aTyr Pharma Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
0
10
-
10
0
0
0
Gross Profit
0
0
-13
-6
-1
8
0
0
-1
Operating Income
-47
-32
-22
-15
-34
-46
-54
-67
-77
EBITDA
-46
-32
-22
-14
-32
-43
-47
-62
-72
Interest Expense
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
1
1
1
2
1
1
Income Before Tax
-48
-34
-23
-16
-33
-45
-50
-64
-74
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-48
-34
-23
-16
-33
-45
-50
-64
-74
Net Profit Margin
0.00%
0.00%
-3228.91%
-65.38%
0.00%
83.68%
100.00%
100.00%
-717.37%

aTyr Pharma Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-15
-16
-17
-14
-14
-19
-25
-13
-10
-10
Operating Cash Flow
-22
-20
-13
-13
-15
-13
-20
-12
-12
-9
Investing Cash Flow
-1
6
17
-6
-4
3
-20
16
11
15
Financing Cash Flow
7
13
0
18
18
17
29
0
0
0
Change in Cash
-15
0
4
0
-1
7
-11
4
-1
5

aTyr Pharma Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-48
-34
-23
-16
-33
-45
-50
-64
-74
Operating Cash Flow
-42
-31
-20
-15
-33
-41
-33
-69
-61
Investing Cash Flow
-27
37
4
6
-91
47
-20
17
-5
Financing Cash Flow
52
-4
1
16
110
5
66
39
66
Change in Cash
-17
1
-13
7
-14
10
12
-12
-1

Mutual Funds that own aTyr Pharma Stock

Check out the Mutual Funds with significant holdings in aTyr Pharma.

Funds
Holdings
Shares Held
Federated Hermes Equity Funds
10.594504%
10391877
Fidelity Mt. Vernon Street Trust
6.919592%
6787250
VANGUARD INDEX FUNDS
3.728501%
3657191
Fidelity Select Portfolios
1.788806%
1754594
Fidelity Salem Street Trust
1.046025%
1026019
See all

Global Institutional Holdings in aTyr Pharma

Funds
Holdings
Federated Hermes Equity Funds
10.59%
Fidelity Mt. Vernon Street Trust
6.92%
Vanguard
3.78%
VANGUARD INDEX FUNDS
3.73%
Fidelity Select Portfolios
1.79%
See all

aTyr Pharma News & Key Events

  • img

    Today's Timeline - 15 September

    Mon, 08:28 PM

    -

    Atyr Pharma stock plummets 80.76% after Phase 3 trial fails primary endpoint for efzofitimod in pulmonary sarcoidosis.

Insights on aTyr Pharma

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 691.6% return, outperforming this stock by 753.8%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, ATYR stock has moved down by -40.8%

About aTyr Pharma

aTyr Pharma, Inc., a biopharmaceutical firm established in San Diego, California, in 2005, is dedicated to the discovery and advancement of therapeutic solutions. Operating within the United States, the company's research focuses on pioneering novel immunological pathways to address various medical conditions. Its primary investigational drug, efzofitimod, functions as a selective modulator of NRP2. This compound is currently undergoing a Phase III clinical trial for pulmonary sarcoidosis. Additionally, efzofitimod is being evaluated in a Phase 1b/2a clinical study for the treatment of other interstitial lung diseases (ILDs), including conditions such as chronic hypersensitivity pneumonitis and ILDs linked to connective tissue diseases. Beyond its lead candidate, aTyr Pharma's pipeline features ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase, which is in preclinical stages of development for combating fibrosis. The company is also progressing with ATYR0750, a domain sourced from alanyl-tRNA synthetase, intended for the management of liver disorders. Furthermore, aTyr Pharma has entered into a strategic collaboration and licensing agreement with Kyorin Pharmaceutical Co., Ltd. This partnership is focused on the development and commercialization of efzofitimod for interstitial lung diseases specifically within the Japanese market.
OrganisationaTyr Pharma
Headquarters10240 Sorrento Valley Road, San Diego, CA, 92121, US
IndustryBiotechnology
CEOSanjay S. Shukla
E-voting on sharesClick here to vote

Key Management of aTyr Pharma

Name

Title

Dr. Sanjay S. Shukla M.D., M.S.

President, CEO & Director

Ms. Nancy E. Denyes Krueger J.D.

General Counsel & Corporate Secretary

Ms. Ashlee Dunston

Director of Investor Relations & Corporate Communications

FAQs

What is aTyr Pharma share price today?

aTyr Pharma share price today is $0.34 as on at the close of the market. aTyr Pharma share today touched a day high of $0.41 and a low of $0.32.

What is the 52 week high and 52 week low for aTyr Pharma share?

aTyr Pharma share touched a 52 week high of $1.12 on and a 52 week low of $0.32 on . aTyr Pharma stock price today i.e. is closed at $0.34,which is 69.86% down from its 52 week high and 4.20% up from its 52 week low.

What is aTyr Pharma's market capitalisation today?

aTyr Pharma market capitalisation is $0.00T as on .

How to invest in aTyr Pharma Stock (ATYR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for aTyr Pharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in aTyr Pharma Shares that will get you 4.4431 shares as per aTyr Pharma share price of $0.34 per share as on September 25, 2026 at 8:46 am IST.

What is the minimum amount required to buy aTyr Pharma Stock (ATYR) from India?

Indian investors can start investing in aTyr Pharma (ATYR) shares with as little as ₹95.8125 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.13 in aTyr Pharma stock (as per the Rupee-Dollar exchange rate as on ). Based on aTyr Pharma share’s latest price of $0.34 as on September 25, 2026 at 8:46 am IST, you will get 29.6209 shares of aTyr Pharma. Learn more about fractional shares .